Furthermore, multivariate analysis revealed that LCN2 low expression status was a significant adverse prognostic factor for overall survival of GC patients (p = 0.04), as well as tumor invasion and lymph node metastasis (Fig. 5C). This evidence concerns the gene LCN2 and neoplasm.